Clinical investigations have demonstrated a strong correlation between high levels of TIMP-1 expression and poor prognosis or tumor growth in various malignancies, including lung cancer, brain prostate cancer, breast cancer, colon cancer, and others42–48. Here, TIMP1 is linked to malignant colon neoplasm.